focus -WSS

focus

author：hotspot 2025-09-30 16:26:50 - browse：17

Adam's take main illustration — Molly Ferguson/STAT

I am one week away from the launch of my weekly email newsletter! It’s called Adam’s Biotech Scorecard, and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week? Unfiltered, uncompromising, and (hopefully) valuable insight and analysis from the intersection of Wall Street and biotech. Plus, a few dashes of fun.

Do you have a biotech-related question you want me to answer in the newsletter? Send me an email at [email protected].

This week: A preview of Intra-Cellular Therapies’ Phase 3 study in major depressive disorder, and a couple of liver-disease physician perspectives on Rezdiffra, the newly approved treatment for MASH from Madrigal Pharmaceuticals.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： White House calls on federal agencies to crack down on AI abuses

entertainment

WSS

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Why palliative psychiatry is worth discussing

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

UCSF medical school apologizes for unethical prisoner experiments

Sanofi CEO defends move to abandon profit guidance, boost research

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

explore

focus

focus

In Memoriam: Notable people who died in 2023

Antivenom research: Lessons from HIV applied in search for universal antidote

Trump demands the U.S. pay no more for drugs than other countries … again

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Novavax promises a turnaround & Lilly roils the obesity market

The Harvard botanist who searched for psychedelics in the Amazon

Supreme Court strikes down use of affirmative action

A solution to the after

leisure time

Medicare inequities exacerbate Puerto Rico’s health disparities

Alabama frozen embryo ruling has major implications for IVF clinics

With competition flaring, obesity drug hits goal in liver disease study

NIH study of ME/CFS points to clear biological hallmarks

Excited delirium, Elijah McClain, and emergency physicians

The Harvard botanist who searched for psychedelics in the Amazon

hotspot

entertainment

hotspot

explore